NIH-funded research R01 grant

Understanding how brain cells respond after injury

Official title: Microglial process convergence following brain injury

Funded at Virginia Commonwealth University · NIH-10876937 · Data updated 2026-11-12

This study looks at how special immune cells in the brain help heal after a traumatic brain injury, using pigs to learn more about their role, with the hope of finding better treatments for people with similar injuries.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVirginia Commonwealth University
NIH-funded
Lab location1 site (Richmond, United States)
Project startAugust 1, 2023
Project endJuly 31, 2027
Funding year2024
Award (this year)$557,339
NIH project number5R01NS128104-02
Project IDNIH-10876937 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults who have experienced a traumatic brain injury, particularly those with ongoing symptoms.

Less likely to help

Patients with chronic brain injuries or those who have not experienced recent trauma may not benefit from this research.

What this research studies

This research investigates the role of microglia, the brain's immune cells, in the aftermath of traumatic brain injury (TBI). It focuses on how these cells converge on damaged areas in the brain, particularly in higher-order mammals like pigs, to understand their potential healing effects. By studying these processes, the research aims to uncover mechanisms that could lead to better treatments for TBI in humans. The approach includes comparing responses in different animal models to identify effective therapeutic strategies.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that improve recovery outcomes for individuals suffering from traumatic brain injuries.

How similar studies have gone: While there has been progress in understanding neuroinflammatory responses in rodents, this specific approach using higher-order mammals like pigs is relatively novel and has not been extensively tested.

Where this research is happening

  • Virginia Commonwealth University
    Richmond, United States
    Active

Researchers

  • Principal investigator: Lafrenaye, Audrey D — Virginia Commonwealth University
  • Study coordinator: Lafrenaye, Audrey D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.